Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Pfizer inlicenses Schering's ADP receptor antagonist program

Feb. 4, 2005

Low recurrence of ulcer bleeding found with an aspirin plus esomeprazole regimen

Jan. 28, 2005

Sulfatides enhance platelet and platelet-leukocyte aggregation

Jan. 26, 2005

France requests further information on Exanta for AF

Jan. 26, 2005

New anticoagulant agents from Bayer

Jan. 24, 2005

Enrollment completed in phase II PAOD trial of NCX-4016

Jan. 24, 2005

CR-001 shows potential as antithrombosis drug

Jan. 19, 2005

Novo Nordisk makes progress with NovoSeven

Jan. 10, 2005

Adolor to copromote Arixtra with GlaxoSmithKline

Jan. 10, 2005

Five Aventis patents disclose novel antithrombotic agents

Jan. 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...